These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10836334)

  • 21. Nasal Nitric Oxide in Primary Immunodeficiency and Primary Ciliary Dyskinesia: Helping to Distinguish Between Clinically Similar Diseases.
    Zysman-Colman ZN; Kaspy KR; Alizadehfar R; NyKamp KR; Zariwala MA; Knowles MR; Vinh DC; Shapiro AJ
    J Clin Immunol; 2019 Feb; 39(2):216-224. PubMed ID: 30911954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased arginase activity in cystic fibrosis airways.
    Grasemann H; Schwiertz R; Matthiesen S; Racké K; Ratjen F
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1523-8. PubMed ID: 16166623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airway nitric oxide in asthmatic children and patients with cystic fibrosis.
    Dötsch J; Demirakça S; Terbrack HG; Hüls G; Rascher W; Kühl PG
    Eur Respir J; 1996 Dec; 9(12):2537-40. PubMed ID: 8980966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis.
    Grasemann H; Michler E; Wallot M; Ratjen F
    Pediatr Pulmonol; 1997 Sep; 24(3):173-7. PubMed ID: 9330413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of nitric oxide measurements to detect primary ciliary dyskinesia.
    Boon M; Meyts I; Proesmans M; Vermeulen FL; Jorissen M; De Boeck K
    Eur J Clin Invest; 2014 May; 44(5):477-85. PubMed ID: 24597492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia.
    Regnis JA; Zeman KL; Noone PG; Knowles MR; Bennett WD
    Exp Lung Res; 2000; 26(3):149-62. PubMed ID: 10813088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Nasal Nitric Oxide in Primary Ciliary Dyskinesia and Other Respiratory Conditions in Children.
    Paternò S; Pisani L; Zanconato S; Ferraro VA; Carraro S
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical application of nasal nitric oxide measurement.
    Carraro S; Cutrone C; Cardarelli C; Zanconato S; Baraldi E
    Int J Immunopathol Pharmacol; 2010; 23(1 Suppl):50-2. PubMed ID: 20152081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary metabolism of nitric oxide (NO) in patients with cystic fibrosis].
    Grasemann H; Ratjen F
    Pneumologie; 2002 Jun; 56(6):376-81. PubMed ID: 12063621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study.
    Grasemann H; Grasemann C; Kurtz F; Tietze-Schillings G; Vester U; Ratjen F
    Eur Respir J; 2005 Jan; 25(1):62-8. PubMed ID: 15640324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections.
    Joensen O; Paff T; Haarman EG; Skovgaard IM; Jensen PØ; Bjarnsholt T; Nielsen KG
    PLoS One; 2014; 9(12):e115584. PubMed ID: 25542036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proof of Concept: Very Rapid Tidal Breathing Nasal Nitric Oxide Sampling Discriminates Primary Ciliary Dyskinesia from Healthy Subjects.
    Holgersen MG; Marthin JK; Nielsen KG
    Lung; 2019 Apr; 197(2):209-216. PubMed ID: 30762092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.
    Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H
    Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen stasis and airway nitrosative stress in human primary ciliary dyskinesia.
    Gaston B; Smith LA; Davis MD; Saunders J; Daniels I; Horani A; Brody SL; Giddings O; Zhao Y; Marozkina N
    Am J Physiol Lung Cell Mol Physiol; 2024 Apr; 326(4):L468-L476. PubMed ID: 38318660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of nitric oxide synthases in primary ciliary dyskinesia.
    Degano B; Valmary S; Serrano E; Brousset P; Arnal JF
    Hum Pathol; 2011 Dec; 42(12):1855-61. PubMed ID: 21663943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Nitric Oxide Levels and Infections by Ultrastructure and Genotype in Primary Ciliary Dyskinesia.
    Pifferi M; Boner AL; Gracci S; Fonnesu R; Maj D; Donzelli G; Michelucci A; Cangiotti A; Bertini V; Valetto A; Caligo MA; Miccoli M; Peroni D; Bush A
    Chest; 2022 Dec; 162(6):1265-1276. PubMed ID: 35777446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airway ciliary dysfunction and sinopulmonary symptoms in patients with congenital heart disease.
    Garrod AS; Zahid M; Tian X; Francis RJ; Khalifa O; Devine W; Gabriel GC; Leatherbury L; Lo CW
    Ann Am Thorac Soc; 2014 Nov; 11(9):1426-32. PubMed ID: 25302410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia.
    Pifferi M; Bush A; Maggi F; Michelucci A; Ricci V; Conidi ME; Cangiotti AM; Bodini A; Simi P; Macchia P; Boner AL
    Eur Respir J; 2011 Mar; 37(3):572-7. PubMed ID: 21273388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis.
    Grasemann H; Tullis E; Ratjen F
    J Cyst Fibros; 2013 Sep; 12(5):468-74. PubMed ID: 23333044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hand-held tidal breathing nasal nitric oxide measurement--a promising targeted case-finding tool for the diagnosis of primary ciliary dyskinesia.
    Marthin JK; Nielsen KG
    PLoS One; 2013; 8(2):e57262. PubMed ID: 23437356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.